Attached files
| file | filename |
|---|---|
| 10-K - NUTRA PHARMA CORP | v181067_10k.htm |
| EX-31.1 - NUTRA PHARMA CORP | v181067_ex31-1.htm |
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Nutra Pharma Corp. (the “Company”) on Form
10-K for the period ending December 31, 2009, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Rik J.
Deitsch, Chief Executive Officer and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
/s/ Rik
J. Deitsch
|
|
|
Rik
J. Deitsch
|
|
|
Chief
Executive Officer and Chief Financial Officer
|
|
|
Date:
April 15, 2010
|
This
certification accompanies this Report pursuant to §906 of the Sarbanes-Oxley Act
of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act
of 2002, be deemed filed by the registrant for the purposes of §18 of the
Securities Exchange Act of 1934, as amended. This certification shall not be
incorporated by reference into any filing under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended (whether made before
or after the date of this Report), irrespective of any general incorporation
language contained in such filing.
A signed
original of this written statement required by §906 has been provided to the
registrant and will be retained by the registrant and furnished to the
Securities and Exchange Commission or its staff upon request.